Author:
Gudiwada Mohan Chandra Vinay Bharadwaj,Gaddam Vinuthna,Rahman Maheen,Jasti Jaswanth R,Bhalodia Paritaben,Jitta Sahas Reddy
Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Statin safety and associated adverse events: a scientific statement from the American Heart Association;Newman CB;Arterioscler Thromb Vasc Biol,2019
2. Pleiotropic effects of statins on the cardiovascular system;Oesterle A;Circ Res,2017
3. Beneficial effects of statins on the rates of hepatic fibrosis, hepatic decompensation, and mortality in chronic liver disease: a systematic review and meta-analysis;Kamal S;Am J Gastroenterol,2017
4. Addition of statins to the standard treatment in patients with cirrhosis: safety and efficacy;Muñoz AE;World J Gastroenterol,2021
5. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial;Pose E;Lancet Gastroenterol Hepatol,2020